Functional polymorphism of −141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia
- 16 November 1998
- journal article
- Published by Elsevier in Psychiatry Research
- Vol. 81 (2) , 117-123
- https://doi.org/10.1016/s0165-1781(98)00092-4
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 34 references indexed in Scilit:
- Analysis of the 5′-Flanking Promoter Region of the 5-HT2A Receptor Gene in SchizophreniaNeuropsychopharmacology, 1997
- Effects of Dopaminergic Transmission Interruption on the D2 Receptor Isoforms in Various Cerebral TissuesJournal of Neurochemistry, 1992
- Haloperidol treatment increases D2 dopamine receptor protein independently of RNA levels in miceLife Sciences, 1991
- Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brainJournal of Molecular Neuroscience, 1990
- Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA levelNeuroscience Letters, 1990
- 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptomsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- DOPAMINE D2 RECEPTORS IN SCHIZOPHRENIA STUDIED IN VIVOThe Lancet, 1986
- DOPAMINE RECEPTORS AND SCHIZOPHRENIA: DRUG EFFECT OR ILLNESS?The Lancet, 1980
- Dopaminergic mechanisms in schizophrenia: The antipsychotic effect and the disease processLife Sciences, 1978
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977